Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells

Journal of Gastroenterology and Hepatology (Australia)

Volumn 16, Issue 3, 2001, Pages 309-316

  Ito, Akihiko ^a   Kanto, Tatsuya ^a   Kuzushita, Noriyoshi ^a   Tatsumi, Tomohide ^a   Sugimoto, Yoshiko ^a   Miyagi, Takuya ^a   Takehara, Tetsuo ^a   Katayama, Kazuhiro ^b   Mochizuki, Kiyoshi ^a   Hiramatsu, Naoki ^a   Kasahara, Akinori ^a   Yoshiya, Ikuto ^a   Sasaki, Yutaka ^a   Hori, Masatsugu ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA KOSEI NENKIN HOSPITAL   (Japan)

Author keywords

0201; Cytotoxic T cell precursor frequency; Cytotoxic T lymphocyte; Dendritic cells; Hepatitis C virus; Human leukocyte antigen A; Human leukocyte antigen A24

Indexed keywords

CHROMIUM 51; CONCANAVALIN A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEPATITIS C ANTIBODY; HLA A ANTIGEN; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 7;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NATURAL KILLER CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0035031066     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2001.02383.x     Document Type: Article

References (32)

1. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis
2. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus
3. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
4. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection
5. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C
6. Plasmid DNA-based immunization for hepatitis C virus structural proteins: Immune response in mice
7. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA-A2.1 binding motif
8. Cytotoxic T lymphocyte (CTL) response of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1
9. The dendritic cell system and its role in immunogenicity
10. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
11. Proliferating dendritic cell progenitors in human blood
12. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
13. Efficient presentation of soluble antigen by cultured human dendritic cells mainrained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
14. Generation of antigen-specific CD8-3 CTLs from naive precursors
15. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from Melan-A/MART-1 self antigen
16. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo
17. Therapy with murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T-cells, B7 costimulation and T helper cell 1-associated cytokines
18. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
19. Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells
20. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs
21. Complete HLA-A DNA typing using the PCR-RFLP method combined with allele group- and sequence-specific amplification
22. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers
23. MHC ligands and peptide motifs: First listing
24. Structure and organization of the hepatitis C virus genome isolated from human carriers
25. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
26. Identification of A2restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome
27. Induction in vitro of a primary human antiviral cytotoxic T cell response
28. HLA class Irestricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release
29. HLA B44-restricted cytotoxic T lymphocytes recognizing an epitope on hepatitis C virus nucleocapsid protein
30. Prominent roles of secondary anchor residues in peptide binding to HLA-A24 human class I molecules
31. Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype
32. HLA-A2-binding peptides cross-react not only within the A2 subgroup but also with other HLA-A locus allelic products